Agilent LC/MS Solutions That Are Clearly Better
Only Agilent LC/MS platforms let you take full advantage of UHPLC and HPLC-Chip separations for your most demanding qualitative and quantitative analyses.
Clearly Better Together
Only Agilent LC/MS platforms are able to unlock the full power of Agilent’s 1290 Infinity LC and 1200 HPLC-Chip/MS technologies. Our integrated, Agilent-reliable Q-TOF and Triple Quadrupole systems let you take full advantage of UHPLC and HPLC-Chip separations—providing high-performance, ultra-competitive solutions for the most demanding qualitative and quantitative analyses.
Clearly Better Separations
With the industry’s widest power range, the Agilent 1290 Infinity LC delivers faster, more sensitive, higher resolution separations, plus unprecedented methods flexibility.
For the highest sensitivity for small-volume samples, Agilent’s 1200 HPLC-Chip/MS offers simpler, better nanoflow separations and faster setup—along with interchangeable workflows that maximize your productivity.
Clearly Better MS Analysis
Ultra-High Definition Q-TOF Technology in our 6500 Series Accurate-Mass Q-TOF platforms provides femtogram-level sensitivity for low-abundance compounds. And Agilent 6400 Series Triple Quadrupole systems take sensitivity to sub-femtogram levels, while also achieving better reproducibility.
Get a free LC/MS compendium to find out how Agilent’s Clearly Better LC/MS solutions can help you extract every bit of information from the most challenging samples: www.agilent.com/chem/together
ref="http://altfarm.mediaplex.com/ad/ck/14123-91584-24870-3">
RAFA 2024: Giorgia Purcaro on Multidimensional GC for Mineral Oil Hydrocarbon Analysis
November 27th 2024Giorgia Purcaro from the University of Liège was interviewed at RAFA 2024 by LCGC International on the benefits of modern multidimensional GC methods to analyze mineral oil aromatic hydrocarbons (MOAH) and mineral oil saturated hydrocarbons (MOSH).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Identifying Antioxidative Properties in Berries with UHPLC-MS
Published: November 27th 2024 | Updated: November 27th 2024A recent study identified and quantified anthocyanin (which are known for their antioxidative properties and potential effectiveness against depression) in blueberries, blackberries, black mulberries, and cranberries using ultra high-pressure liquid chromatography (UHPLC) followed by in vivo evaluation of their antidepressant-like activities.
In Conversation with the EAS Award Winner for Outstanding Achievements in Mass Spectrometry
November 27th 2024As part of our EAS 2024 coverage, we recently interviewed Benjamin Garcia of the Washington University in St. Louis about his work and his being awarded the EAS Award for Outstanding Achievements in Mass Spectrometry.
